Induction therapy with PD-1 antibody combined with platinum-based doublet chemotherapy for locally-advanced non-small cell lung cancer: A randomised controlled, open-label, phase 2 trial

被引：0
|
作者：
Wang, Suyu [1 ]
Zhang, Peng [1 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Thorac Surg, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8044
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial
    Kim, Edward S.
    Neubauer, Marcus
    Cohn, Allen
    Schwartzberg, Lee
    Garbo, Lawrence
    Caton, John
    Robert, Francisco
    Reynolds, Craig
    Katz, Terry
    Chittoor, Sreeni
    Simms, Lorinda
    Saxman, Scott
    LANCET ONCOLOGY, 2013, 14 (13): : 1326 - 1336
  • [12] Platinum-based Doublet Chemotherapy plus Bevacizumab Without Bevacizumab Maintenance in Advanced Non-small Cell Lung Cancer (NSCLC)
    Noroxe, Dorte Schou
    Wallerek, Sandra
    Sorensen, Jens Benn
    ANTICANCER RESEARCH, 2013, 33 (08) : 3275 - 3278
  • [13] The power of immunotherapy plus platinum-based chemotherapy for locally advanced or early stage non-small cell lung cancer
    Hofman, Paul
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
  • [14] Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy.
    Yi, S. Y.
    Ahn, M.
    Park, J. Y.
    Lee, H. R.
    Lee, J.
    Park, Y. H.
    Ahn, J. S.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [15] Maintenance Anlotinib After Induction Therapy With Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Phase 2 Study
    Shu, Y.
    Liu, Y.
    Cui, J.
    Chen, X.
    Miao, L.
    Li, Y.
    Zhu, X.
    He, J.
    Chen, P.
    Dai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1069 - S1069
  • [16] Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non-Small Cell Lung Cancer
    Otterson, Gregory A.
    Villalona-Calero, Miguel A.
    Hicks, William
    Pan, Xueliang
    Ellerton, John A.
    Gettinger, Scott N.
    Murren, John R.
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2466 - 2473
  • [17] A multicenter, open-label, phase IIIB trial of erlotinib in patients with advanced non-small cell lung cancer
    Hainsworth, J
    Spigel, D
    O'Neill, V
    Klencke, B
    LUNG CANCER, 2005, 49 : S246 - S247
  • [18] Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
    Pirker, Robert
    Pereira, Jose R.
    Szczesna, Aleksandra
    von Pawel, Joachim
    Krzakowski, Maciej
    Ramlau, Rodryg
    Vynnychenko, Ihor
    Park, Keunchil
    Yu, Chih-Teng
    Ganul, Valentyn
    Roh, Jae-Kyung
    Bajetta, Emilio
    O'Byrne, Kenneth
    de Marinis, Filippo
    Eberhardt, Wilfried
    Goddemeier, Thomas
    Emig, Michael
    Gatzemeier, Ulrich
    Pirker, R.
    Thatcher, N.
    Armand, J. P.
    Camus, P.
    Victor, N.
    Emig, M.
    Mueser, M.
    Pilz, K.
    Goddemeier, T.
    Montaner, I.
    Lachs, Martin
    Hoang-Sayag, Loan
    Alvarez, A.
    Coppola, F.
    Recondo, G.
    Richardet, E.
    Kirsten, F.
    Karapetis, C.
    Parente, P.
    Michael, M.
    White, S.
    Boyce, A.
    Lewis, C.
    Slancar, M.
    Pavlakis, N.
    Abdi, E.
    Underhill, C.
    Pittman, K.
    Burghuber, O.
    Pirker, R.
    Ruckser, R.
    Ulsperger, E.
    LANCET, 2009, 373 (9674): : 1525 - 1531
  • [19] Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
    Mok, Tony S. K.
    Wu, Yi-Long
    Kudaba, Iveta
    Kowalski, Dariusz M.
    Cho, Byoung Chul
    Turna, Hande Z.
    Castro, Gilberto, Jr.
    Srimuninnimit, Vichien
    Laktionov, Konstantin K.
    Bondarenko, Igor
    Kubota, Kaoru
    Lubiniecki, Gregory M.
    Zhang, Jin
    Kush, Debra
    Lopes, Gilberto
    LANCET, 2019, 393 (10183): : 1819 - 1830
  • [20] Randomized trial of feiyanning decoction in combination with platinum-based chemotherapy in advanced non-small cell lung cancer patients
    Xu, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S493 - S493
12345